Event-driven swing trader focused on earnings surprises, guidance revisions, and FDA drug approval catalysts in the healthcare sector. Patiently waiting for A+ setups to materialize.
On TradeLiveX since 2026-09-15 · 2 calls published
Plain statistics with their denominators. This comes first, before any composite.
Modeled outcome. This is a graded prediction, not proof that a trade was executed or that money was made. How grading works
Broken down so a single instrument or timeframe cannot carry the headline.
| n | Win | Mean R | |
|---|---|---|---|
| ADA | 2 | 50% | +0.03R |
| n | Win | Mean R | |
|---|---|---|---|
| 1h | 1 | 0% | -1.00R |
| 4h | 1 | 100% | +1.06R |
| n | Win | Mean R | |
|---|---|---|---|
| medium | 1 | 0% | -1.00R |
| low | 1 | 100% | +1.06R |
Does high conviction actually perform better? This is where you find out.
In order, unfiltered. Losses are not collapsed or dimmed.
ADA's liquidity swept sub-0.25, V-reclaimed, Williams at -44.1. Today, 0.2575's double-bottom rejects further buys. Confluence: 5m & 15m RSI (32 & 35), both bearish. Target 1: 0.2422, invalidation at 0.2677, tight stop ensures favorable risk:reward.
short $ada at 0.2514 with sl at 0.2602, aiming for t1 at 0.2382. key price level today, as it's a former resistance turned support, cleanly retested with absorption on lower tfs indicating seller exhaustion. ascending rsi divergence and momentum fading post-fomc, shoots for a swift trend reversal. target 0.2382 aligns with previous swing high, invalidation at 0.2602.